Replies to post #475813 on NorthWest Biotherapeutics Inc (NWBO)

[Bob_LobLaw]

Do you think Dr Brem’s data will not infringe on the journal embargo? I think there is a solid chance we do not see publication for quite a bit

Added after seeing your edit: His comment at NYAS just mentioned June and made no reference to ASCO so perhaps they have a presentation lined out elsewhere. And much like NYAS, perhaps a non profit event would be allowed and not violate embargo

[abc1212]

Total guess flipper but what if

which to me is code for something related to tumor response/reaction

they found a way to distinguish between pseudo progression and actual tumour

He did say "using each patient as a control and having another dimension of efficacy"

As I say, only guessing and probably way off the mark but would like to hear your thoughts

Whatever it is, can't wait to find out what it is



.

[pgsd]

"Dr. Steven Brem’s group at U. Penn will present an additional dimension of efficacy in June"

Newly released final abstracts are out for Asco and do not appear to show any additional DCVax presentations or anything for Dr Brem (unless I have missed it), Perhaps the data may be included in Marnix's Industry expert theatre presentation ? I just checked the video and he does mention June as when the data will be presented.

https://meetings.asco.org/abstracts-presentations/search?query=*&q=*&sortBy=AbstractBrowse&filters=%7B%22meetingTypeName%22:%5B%7B%22key%22:%22ASCO%20Annual%20Meeting%22%7D%5D,%22meetingYear%22:%5B%7B%22key%22:2022%7D%5D,%22presentationType%22:%5B%7B%22key%22:%22Abstract%20Presentation%22%7D,%7B%22key%22:%22Poster%22%7D,%7B%22key%22:%22Abstract%22%7D%5D%7D&size=50&cmpid=ws_ascoorg_am_abstracts_sno_twitter_all_042722____aware_image-text_